Ketamine vs Fentanyl for Traumatic Injury Pain Management
(PAIN Trial)
Trial Summary
What is the purpose of this trial?
The Prehospital Analgesia INtervention trial (PAIN) is a proposed 4 year (3-year enrollment) multicenter, prehospital, randomized, double-blind, clinical trial that will enroll approximately 994 patients at select LITES Network sites. The objective is to perform a prospective, interventional, randomized trial among prehospital trauma patients with compensated shock (SI≥0.9) and an indication for pain management, comparing patient centered outcomes following prehospital administration of ketamine hydrochloride versus fentanyl citrate.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the drug ketamine compared to fentanyl for traumatic injury pain management?
Research shows that low-dose ketamine provides greater pain control compared to fentanyl in prehospital settings, with a significant reduction in pain and a higher proportion of patients experiencing at least a 50% reduction in pain. Additionally, ketamine has been associated with fewer adverse events, supporting its effectiveness as a pain management option.12345
Is it safe to use ketamine and fentanyl for pain management in humans?
Research shows that both ketamine and fentanyl are generally safe for pain management in humans, with studies reporting no significant adverse events when used in controlled settings. Ketamine, in particular, has been noted for its effective pain relief without significant side effects in prehospital and emergency department settings.23678
How does the drug Ketamine differ from Fentanyl for traumatic injury pain management?
Ketamine, when used with Fentanyl, may provide better pain relief and reduce the need for additional opioids compared to using Fentanyl alone. Ketamine can be administered intranasally, which is a non-invasive method, and it may also help decrease the risk of developing PTSD and chronic pain after a traumatic injury.12359
Research Team
Jason Sperry, MD, MPH
Principal Investigator
University of Pittsburgh
Eligibility Criteria
The PAIN trial is for trauma patients with compensated shock (SI>0.9) who need IV pain medication and are being transported to a LITES Trauma center. It's not for those under 18, women under 50, anyone with high blood pressure (SBP>180 mmHg), prior pain meds or advanced airway management, prisoners, allergy to the drugs tested, or if they or family object.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Prehospital Treatment
Participants receive prehospital administration of ketamine hydrochloride or fentanyl citrate for pain management
Hospitalization
Participants are monitored and treated in the hospital following prehospital intervention
Follow-up
Participants are monitored for long-term outcomes including opioid use and pain assessment
Treatment Details
Interventions
- Fentanyl Citrate (Opioid Analgesic)
- Ketamine Hydrochloride (NMDA Receptor Antagonist)
Fentanyl Citrate is already approved in Canada for the following indications:
- Severe pain
- Chronic pain
- Breakthrough pain
- Preoperative anesthesia
- Postoperative pain
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jason Sperry
Lead Sponsor
United States Department of Defense
Collaborator
Pete Hegseth
United States Department of Defense
Chief Executive Officer
Bachelor's degree in Political Science from Princeton University, JD from Harvard Law School
Lisa Hershman
United States Department of Defense
Chief Medical Officer since 2021
MD from Uniformed Services University of the Health Sciences